prognosis

Comorbidity and ovarian cancer survival in Denmark, 1995–2005: a population-based cohort study
M. S. Tetsche, M. Nørgaard, J. Jacobsen, P. Wogelius, H. T. Sørensen

International Journal of Gynecologic Cancer May 2008, 18 (3) 421-427; DOI: 10.1111/j.1525-1438.2007.01036.x
Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening
A. V. YEMELYANOVA, J. A. COSIN, M. A. BIDUS, C. R. BOICE, J. D. SEIDMAN

International Journal of Gynecologic Cancer May 2008, 18 (3) 465-469; DOI: 10.1111/j.1525-1438.2007.01058.x
Expression of hypoxia-inducible factor 1α gene affects the outcome in patients with ovarian cancer
R. SHIMOGAI, J. KIGAWA, H. ITAMOCHI, T. IBA, Y. KANAMORI, T. OISHI, M. SHIMADA, S. SATO, W. KAWAGUCHI, N. TERAKAWA

International Journal of Gynecologic Cancer May 2008, 18 (3) 499-505; DOI: 10.1111/j.1525-1438.2007.01055.x
LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking
A. K. Lindström, K. Ekman, U. Stendahl, T. Tot, R. Henriksson, H. Hedman, D. Hellberg

International Journal of Gynecologic Cancer Feb 2008, 18 (2) 312-317; DOI: 10.1111/j.1525-1438.2007.01021.x
Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix
S. Y. Tong, Y. S. Lee, J. S. Park, S. E. Namkoong

International Journal of Gynecologic Cancer Oct 2007, 17 (6) 1307-1313; DOI: 10.1111/j.1525-1438.2007.00933.x
Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow
C Schindlbeck, P Hantschmann, M Zerzer, B Jahns, D Rjosk, W Janni, B Rack, H Sommer, K Friese

International Journal of Gynecologic Cancer Sep 2007, 17 (5) 1047-1055; DOI: 10.1111/j.1525-1438.2007.00920.x
The prognostic significance of leukocytosis in cervical cancer
A. Garcia-Arias, L. Cetina, M. Candelaria, E. Robles, A. Dueñas-González

International Journal of Gynecologic Cancer Feb 2007, 17 (2) 465-470; DOI: 10.1111/j.1525-1438.2007.00816.x
Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables
P. Dursun, K. Yuce, A. Usubutun, A. Ayhan

International Journal of Gynecologic Cancer Jan 2007, 17 (1) 164-173; DOI: 10.1111/j.1525-1438.2007.00798.x
Role of [¹⁸F]fluoro-2-deoxy-D-glucose positron emission tomography in re-recurrent cervical cancer
C.-T. Lin, T.-C. Yen, T.-C. Chang, K.-K. Ng, C.-S. Tsai, K.-C. Ho, C.-H. Lai

International Journal of Gynecologic Cancer Oct 2006, 16 (6) 1994-2003; DOI: 10.1111/j.1525-1438.2006.00729.x
Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix
Jhtg Fregnani, M. R.D.O Latorre, P. R. Novik, A. Lopes, F. A. Soares

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1188-1194; DOI: 10.1136/ijgc-00009577-200605000-00037

Main menu

prognosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

prognosis

Pages